HELX
BATS
$38.46
FRANKLIN GENOMIC ADVANCEMENTS ETF (HELX)
Sector:
Healthcare
Net assets
$28M
Inception date
February 25, 2020
Expense ratio
0.50%
Sharpe Ratio
1.49
Price Chart
Valuation
Net assets$28M
Forward P/E26.26
P/S8.16
P/B6.78
Profitability
Profit Margin-10.8%
Operating Margin-137.6%
Financial Health
Debt-to-Equity-69.3%
Growth & Risk
EPS 5Y CAGR+3.45%
Revenue 5Y CAGR+35.75%
FCF 5Y CAGR+13.85%
Dividends 5Y CAGR+22.57%
Beta (5Y)0.92
Sharpe Ratio1.49